AI Summary & Key Takeaways
AI InsightProlongationof the stage 5 chronic kidney disease follow-up may imply postponement of the cost of other high-cost RRTs.
📌 3 Key Takeaways
Özet
Objective: It is still unclear which parameters will be used when starting renal replacement therapies (RRT) in end stagekidney disease patients. We planned this retrospective study to determine the eGFR in the transition to RRT in our patientpopulation and the RRT preferences with laboratory values.Materials and Methods: We data from patients who transferred to RRT from low-clearance polyclinic between 2016 and2017.Results: 57 patients underwent hemodialysis (HD), 13 patients peritoneal dialysis (PD) and 24 patients preemptive kidneytransplantation. In the middle age group (56-75 years), HD was more preferred then preemptive kidney transplantation(p=0.02). In the transition to RRT median eGFR is 8.3 (6.7-9.6) mL/min/1.73 m2. A statistically significant difference wasfound between eGFR values when starting different RRTs (p= 0.005). The median eGFRs for HD is 7.4 (5.9-9) mL/min/1.73m2, for PD 8.6 mL/min/1.73 m2 (7.9-10.6), for transplantation 9.3 (7.25-11.2) mL/min/1.73 m2. This difference was betweenpreemptive transplantation and HD.Conclusion: It is not appropriate to decide the RRT with a single assessment other than acute complications. Prolongationof the stage 5 chronic kidney disease follow-up may imply postponement of the cost of other high-cost RRTs.